{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:35:33Z","timestamp":1759991733152,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00228-017-2195-5","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T11:24:00Z","timestamp":1484220240000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between N-desethylamiodarone\/amiodarone ratio and amiodarone-induced thyroid dysfunction"],"prefix":"10.1007","volume":"73","author":[{"given":"Mikie","family":"Yamato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Oita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutaka","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"issue":"3","key":"2195_CR1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","volume":"30","author":"VR Vorperian","year":"1997","unstructured":"Vorperian VR, Havighurst TC, Miller S, January CT (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30(3):791\u2013798","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2195_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/edrv.22.2.0427","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE (2001) The effects of amiodarone on the thyroid. Endocr Rev 22(2):240\u2013254. doi: 10.1210\/edrv.22.2.0427","journal-title":"Endocr Rev"},{"issue":"12","key":"2195_CR3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/qjmed\/hcg158","volume":"96","author":"J Sidhu","year":"2003","unstructured":"Sidhu J, Jenkins D (2003) Men are at increased risk of amiodarone-associated thyrotoxicosis in the UK. QJM : monthly journal of the Association of Physicians 96(12):949\u2013950","journal-title":"QJM : monthly journal of the Association of Physicians"},{"issue":"6","key":"2195_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1590\/S0004-27302005000600010","volume":"49","author":"BD Schaan","year":"2005","unstructured":"Schaan BD, Cunha CP, Francisconi A, Zottis B, Brum G, Bruch RS, Gus M (2005) Amiodarone-induced thyroid dysfunction in a tertiary center in South Brazil. Arquivos brasileiros de endocrinologia e metabologia 49(6):916\u2013922. doi: 10.1590\/S0004-27302005000600010","journal-title":"Arquivos brasileiros de endocrinologia e metabologia"},{"issue":"6","key":"2195_CR5","first-page":"434","volume":"16","author":"KF Lee","year":"2010","unstructured":"Lee KF, Lee KM, Fung TT (2010) Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population. Hong Kong medical journal = Xianggang yi xue za zhi \/ Hong Kong Academy of Medicine 16(6):434\u2013439","journal-title":"Hong Kong medical journal = Xianggang yi xue za zhi \/ Hong Kong Academy of Medicine"},{"issue":"3","key":"2195_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","volume":"75","author":"S Ahmed","year":"2011","unstructured":"Ahmed S, Van Gelder IC, Wiesfeld AC, Van Veldhuisen DJ, Links TP (2011) Determinants and outcome of amiodarone-associated thyroid dysfunction. Clin Endocrinol 75(3):388\u2013394. doi: 10.1111\/j.1365-2265.2011.04087.x","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2195_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ijcard.2012.02.015","volume":"167","author":"MN Stan","year":"2013","unstructured":"Stan MN, Ammash NM, Warnes CA, Brennan MD, Thapa P, Nannenga MR, Bahn RS (2013) Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease\u2014a cohort study. Int J Cardiol 167(3):821\u2013826. doi: 10.1016\/j.ijcard.2012.02.015","journal-title":"Int J Cardiol"},{"issue":"1","key":"2195_CR8","first-page":"2","volume":"63","author":"I Zosin","year":"2012","unstructured":"Zosin I, Balas M (2012) Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data. Endokrynologia Polska 63(1):2\u20139","journal-title":"Endokrynologia Polska"},{"issue":"2","key":"2195_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","volume":"26","author":"E Martino","year":"1987","unstructured":"Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Lenziardi M, Ceccarelli C, Bambini G, Safran M, Braverman LE, Pinchera A (1987) Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol 26(2):227\u2013237","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2195_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","volume":"91","author":"MD Trip","year":"1991","unstructured":"Trip MD, Wiersinga W, Plomp TA (1991) Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med 91(5):507\u2013511","journal-title":"Am J Med"},{"issue":"11\u201312","key":"2195_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2298\/MPNS1112533A","volume":"64","author":"Z Aleksic","year":"2011","unstructured":"Aleksic Z, Aleksic A (2011) Incidence of amiodarone-induced thyroid dysfunction and predictive factors for their occurrence. Med Pregl 64(11\u201312):533\u2013538","journal-title":"Med Pregl"},{"issue":"23","key":"2195_CR12","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1001\/archinte.1994.00420230115013","volume":"154","author":"E Martino","year":"1994","unstructured":"Martino E, Aghini-Lombardi F, Bartalena L, Grasso L, Loviselli A, Velluzzi F, Pinchera A, Braverman LE (1994) Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med 154(23):2722\u20132726","journal-title":"Arch Intern Med"},{"issue":"1","key":"2195_CR13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","volume":"101","author":"E Martino","year":"1984","unstructured":"Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Pacchiarotti A, Aronin N, Macchia E, Haffajee C et al (1984) Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101(1):28\u201334","journal-title":"Ann Intern Med"},{"issue":"1\u20134","key":"2195_CR14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000180696","volume":"26","author":"E Martino","year":"1987","unstructured":"Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A (1987) Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res 26(1\u20134):158\u2013171","journal-title":"Horm Res"},{"key":"2195_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-6614-4-14","volume":"4","author":"TT Zava","year":"2011","unstructured":"Zava TT, Zava DT (2011) Assessment of Japanese iodine intake based on seaweed consumption in Japan: a literature-based analysis. Thyroid Res 4:14. doi: 10.1186\/1756-6614-4-14","journal-title":"Thyroid Res"},{"issue":"6","key":"2195_CR16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0090-9556(25)08220-0","volume":"21","author":"G Fabre","year":"1993","unstructured":"Fabre G, Julian B, Saint-Aubert B, Joyeux H, Berger Y (1993) Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Drug metabolism and disposition: the biological fate of chemicals 21(6):978\u2013985","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"6","key":"2195_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1067\/mcp.2000.107047","volume":"67","author":"PT Pollak","year":"2000","unstructured":"Pollak PT, Bouillon T, Shafer SL (2000) Population pharmacokinetics of long-term oral amiodarone therapy. Clin Pharmacol Ther 67(6):642\u2013652. doi: 10.1067\/mcp.2000.107047","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2195_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0300-483X(01)00451-6","volume":"166","author":"MW Bolt","year":"2001","unstructured":"Bolt MW, Racz WJ, Brien JF, Massey TE (2001) Effects of vitamin E on cytotoxicity of amiodarone and N-desethylamiodarone in isolated hamster lung cells. Toxicology 166(3):109\u2013118","journal-title":"Toxicology"},{"issue":"9A","key":"2195_CR19","doi-asserted-by":"crossref","first-page":"37R","DOI":"10.1016\/S0002-9149(99)00700-6","volume":"84","author":"PT Pollak","year":"1999","unstructured":"Pollak PT (1999) Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol 84(9A):37R\u201345R","journal-title":"Am J Cardiol"},{"issue":"3","key":"2195_CR20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1139\/y87-062","volume":"65","author":"JF Brien","year":"1987","unstructured":"Brien JF, Jimmo S, Brennan FJ, Ford SE, Armstrong PW (1987) Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol 65(3):360\u2013364","journal-title":"Can J Physiol Pharmacol"},{"issue":"10","key":"2195_CR21","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.28.1934","volume":"28","author":"A Kashima","year":"2005","unstructured":"Kashima A, Funahashi M, Fukumoto K, Komamura K, Kamakura S, Kitakaze M, Ueno K (2005) Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Biol Pharm Bull 28(10):1934\u20131938","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"2195_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2125.2009.03381.x","volume":"67","author":"C Lafuente-Lafuente","year":"2009","unstructured":"Lafuente-Lafuente C, Alvarez JC, Leenhardt A, Mouly S, Extramiana F, Caulin C, Funck-Brentano C, Bergmann JF (2009) Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity. Br J Clin Pharmacol 67(5):511\u2013519. doi: 10.1111\/j.1365-2125.2009.03381.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2195_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/cphy.c150017","volume":"6","author":"S Lee","year":"2016","unstructured":"Lee S, Farwell AP (2016) Euthyroid sick syndrome. Comprehensive Physiology 6(2):1071\u20131080. doi: 10.1002\/cphy.c150017","journal-title":"Comprehensive Physiology"},{"issue":"3","key":"2195_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ehf2.12084","volume":"3","author":"T Hayashi","year":"2016","unstructured":"Hayashi T, Hasegawa T, Kanzaki H, Funada A, Amaki M, Takahama H, Ohara T, Sugano Y, Yasuda S, Ogawa H, Anzai T (2016) Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure. ESC heart failure 3(3):168\u2013176. doi: 10.1002\/ehf2.12084","journal-title":"ESC heart failure"},{"issue":"2","key":"2195_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.amjmed.2004.07.052","volume":"118","author":"A Pingitore","year":"2005","unstructured":"Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118(2):132\u2013136. doi: 10.1016\/j.amjmed.2004.07.052","journal-title":"Am J Med"},{"issue":"1","key":"2195_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijcard.2012.09.064","volume":"168","author":"A Frey","year":"2013","unstructured":"Frey A, Kroiss M, Berliner D, Seifert M, Allolio B, Guder G, Ertl G, Angermann CE, Stork S, Fassnacht M (2013) Prognostic impact of subclinical thyroid dysfunction in heart failure. Int J Cardiol 168(1):300\u2013305. doi: 10.1016\/j.ijcard.2012.09.064","journal-title":"Int J Cardiol"},{"issue":"3","key":"2195_CR27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1523-1755.2005.00169.x","volume":"67","author":"JC Lo","year":"2005","unstructured":"Lo JC, Chertow GM, Go AS, Hsu CY (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67(3):1047\u20131052. doi: 10.1111\/j.1523-1755.2005.00169.x","journal-title":"Kidney Int"},{"issue":"3","key":"2195_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1124\/jpet.106.108993","volume":"319","author":"KM Waldhauser","year":"2006","unstructured":"Waldhauser KM, Torok M, Ha HR, Thomet U, Konrad D, Brecht K, Follath F, Krahenbuhl S (2006) Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther 319(3):1413\u20131423. doi: 10.1124\/jpet.106.108993","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2195_CR29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/hep.20634","volume":"41","author":"P Kaufmann","year":"2005","unstructured":"Kaufmann P, Torok M, Hanni A, Roberts P, Gasser R, Krahenbuhl S (2005) Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology (Baltimore, Md) 41(4):925\u2013935. doi: 10.1002\/hep.20634","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"2195_CR30","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-3565(24)29503-3","volume":"298","author":"MW Bolt","year":"2001","unstructured":"Bolt MW, Card JW, Racz WJ, Brien JF, Massey TE (2001) Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity. J Pharmacol Exp Ther 298(3):1280\u20131289","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2195_CR31","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/endo.134.5.8156930","volume":"134","author":"L Chiovato","year":"1994","unstructured":"Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman LE, Pinchera A (1994) Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 134(5):2277\u20132282. doi: 10.1210\/endo.134.5.8156930","journal-title":"Endocrinology"},{"issue":"24","key":"2195_CR32","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/0006-2952(89)90648-5","volume":"38","author":"SA Beddows","year":"1989","unstructured":"Beddows SA, Page SR, Taylor AH, McNerney R, Whitley GS, Johnstone AP, Nussey SS (1989) Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem Pharmacol 38(24):4397\u20134403","journal-title":"Biochem Pharmacol"},{"issue":"4 Pt 2","key":"2195_CR33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/0002-8703(83)90006-6","volume":"106","author":"DW Holt","year":"1983","unstructured":"Holt DW, Tucker GT, Jackson PR, Storey GC (1983) Amiodarone pharmacokinetics. Am Heart J 106(4 Pt 2):840\u2013847","journal-title":"Am Heart J"},{"issue":"5","key":"2195_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1742-7843.2010.00669.x","volume":"108","author":"N Hanioka","year":"2011","unstructured":"Hanioka N, Matsumoto K, Saito Y, Narimatsu S (2011) Influence of CYP2C8*13 and CYP2C8*14 alleles on amiodarone N-deethylation. Basic & clinical pharmacology & toxicology 108(5):359\u2013362. doi: 10.1111\/j.1742-7843.2010.00669.x","journal-title":"Basic & clinical pharmacology & toxicology"},{"issue":"3","key":"2195_CR35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1507\/endocrj.46.443","volume":"46","author":"K Sato","year":"1999","unstructured":"Sato K, Miyakawa M, Eto M, Inaba T, Matsuda N, Shiga T, Ohnishi S, Kasanuki H (1999) Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. Endocr J 46(3):443\u2013451","journal-title":"Endocr J"},{"issue":"2","key":"2195_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000358270","volume":"3","author":"LM Thienpont","year":"2014","unstructured":"Thienpont LM, Van Uytfanghe K, Van Houcke S, Das B, Faix JD, MacKenzie F, Quinn FA, Rottmann M, Van den Bruel A (2014) A progress report of the IFCC Committee for Standardization of Thyroid Function Tests. European thyroid journal 3(2):109\u2013116. doi: 10.1159\/000358270","journal-title":"European thyroid journal"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2195-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2195-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2195-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T10:27:53Z","timestamp":1749896873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2195-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2195-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2017,1,12]]}}}